Protagonist Therapeutics, Inc. (PTGX)

NASDAQ: PTGX · IEX Real-Time Price · USD

25.61

+0.39 (1.55%)

At close: Apr 19, 2024, 4:00 PM

26.00

+0.39 (1.52%)

After-hours: Apr 19, 2024, 5:19 PM EDT

Protagonist Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	186.73	125.74	123.67	117.37	33.02	82.24	106.04	21.09	4.07
Short-Term Investments	154.89	111.61	203.24	188.45	100.01	46.62	37.97	56.52	7.87
Cash & Cash Equivalents	341.62	237.36	326.9	305.82	133.03	128.86	144.01	77.61	11.93
Cash Growth	43.93%	-27.39%	6.89%	129.89%	3.23%	-10.52%	85.56%	550.37%	-
Receivables	10	0.01	1.57	2.43	6.76	4.59	1.82	0	0
Other Current Assets	3.96	5.71	12.27	7.36	5.53	4.05	5.12	5.64	2.27
Total Current Assets	355.58	243.08	340.74	315.61	145.31	137.5	150.95	83.24	14.21
Property, Plant & Equipment	2.15	4.63	6.73	6.41	7.72	0.86	0.88	0.56	0.61
Long-Term Investments	0	0	0	2	0	0	11.46	10.15	0
Other Long-Term Assets	0.23	0.23	0.23	0.45	1.88	1.11	0.45	0.03	0.03
Total Long-Term Assets	2.37	4.85	6.96	8.86	9.61	1.97	12.79	10.75	0.64
Total Assets	357.95	247.93	347.7	324.47	154.92	139.47	163.73	93.99	14.85
Accounts Payable	0.78	3.71	2.5	5.81	4.05	6.77	1.26	1.16	1.25
Deferred Revenue	0	0	1.6	14.48	41.53	8.22	31.75	0	0
Current Debt	1.14	2.52	2.2	1.46	1.26	0	0	0	0
Other Current Liabilities	19.36	24.96	37.72	18.5	-11.43	11.16	9.55	5.27	1.88
Total Current Liabilities	21.27	31.18	44.02	40.24	35.41	26.16	42.56	6.44	3.13
Long-Term Debt	0	1.14	3.66	4.5	15.76	0	0	0	0
Other Long-Term Liabilities	0	0	0	0.12	23.79	0.8	0.55	0	2.12
Total Long-Term Liabilities	0	1.14	3.66	4.62	39.55	0.8	0.55	0	2.12
Total Liabilities	21.27	32.32	47.67	44.86	74.95	26.96	43.1	6.44	5.25
Total Debt	1.14	3.66	5.86	5.96	17.01	0	0	0	0
Debt Growth	-68.79%	-37.59%	-1.69%	-64.97%	-	-	-	-	-
Retained Earnings	-615.71	-536.76	-409.36	-283.81	-217.66	-140.47	-101.55	-64.59	-27.42
Comprehensive Income	-0.11	-0.36	-0.3	0.03	-0.22	-0.23	-0.01	-0.25	-0.1
Shareholders' Equity	336.68	215.61	300.02	279.61	79.96	112.52	120.63	87.56	-27.4
Net Cash / Debt	340.48	233.7	321.04	299.86	116.02	128.86	144.01	77.61	11.93
Net Cash / Debt Growth	45.69%	-27.21%	7.06%	158.46%	-9.97%	-10.52%	85.56%	550.37%	-
Net Cash Per Share	6.00	4.77	6.93	8.72	4.48	5.76	8.14	11.94	47.41
Working Capital	334.3	211.9	296.72	275.37	109.91	111.35	108.39	76.81	11.08
Book Value Per Share	5.93	4.40	6.48	8.13	3.09	5.03	6.82	13.47	-108.85

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).